Fig. 3: Kaplan–Meier survival analysis in patients with multiple myeloma who underwent ASCT within one year of diagnosis, stratified by S-phase percentage at the time of transplantation (<2%, 2–4.9%, 4.9–9.9%, and ≥10%). | Blood Cancer Journal

Fig. 3: Kaplan–Meier survival analysis in patients with multiple myeloma who underwent ASCT within one year of diagnosis, stratified by S-phase percentage at the time of transplantation (<2%, 2–4.9%, 4.9–9.9%, and ≥10%).

From: Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes

Fig. 3

A PFS. B OS. ASCT autologous stem cell transplantation, MM multiple myeloma, PFS progression-free survival, OS overall survival, NR not reached.

Back to article page